Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04281823 · ClinicalTrials.gov registry record
DeBakey Cardiovascular Magnetic Resonance Study
A clinical trial of Cardiovascular Diseases, sponsored by Dipan Shah.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT04281823: Recruiting study of Cardiovascular Diseases, sponsored by Dipan Shah.
NCT04281823 is a study of Cardiovascular Diseases that is actively recruiting participants, run by Dipan Shah. The registered enrollment target is 100,000 participants, above the 26,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (275% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04281823, a study of Cardiovascular Diseases, is actively recruiting participants, sponsored by Dipan Shah.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
While advancements in cardiac magnetic resonance (CMR) have improved image quality, it is unclear how these improvements are connected to the clinical evaluation of individuals with cardiovascular disease. The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to gain additional pathophysiologic insights into cardiovascular disease, 2) understand how CMR compares to alternative cardiovascular diagnostic modalities, 3) determine how CMR affects clinical management decisions, and 4) establish a link between CMR findings and long term prognosis in patients with known or suspected cardiovascular disease. The ultimate aim is to utilize CMR to improve patient outcomes. CMR techniques to be studies include function, fibrosis, and flow. Focus areas include valvular heart disease, ischemic heart disease, cardiomyopathies, and vascular disease.
Primary Outcome
All-cause mortality, Cardiovascular mortality (acute Myocardial Infarction, sudden death, heart failure, cerebrovascular, procedural), and Non-cardiovascular mortality
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiovascular Magnetic Resonance
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2008-04-01 |
| Est. Completion | 2058-04-01 |
What NCT04281823 shows while recruiting
NCT04281823 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 26,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (275% higher).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular Magnetic Resonance is the first listed.
NCT04281823 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04281823 about?
NCT04281823 is a clinical study titled "DeBakey Cardiovascular Magnetic Resonance Study". While advancements in cardiac magnetic resonance (CMR) have improved image quality, it is unclear how these improvements are connected to the clinical evaluation of individuals with cardiovascular disease. The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to...
What is the current status of trial NCT04281823?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2008-04-01. Estimated completion is 2058-04-01.
What conditions does trial NCT04281823 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT04281823?
The interventions under investigation include: Cardiovascular Magnetic Resonance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04281823?
This trial is sponsored by Dipan Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04281823 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04281823's enrollment target sits among peer trials
100,000 6th of 300 higher than 295 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
- NCT05915299 · 100,000 participants
US National OCS Heart Perfusion (OHP) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI